A Phase 1 Study Evaluating the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Immunogenicity of Single and Multiple Doses of AL003 in Healthy Participants and in Participants with Mild to Moderate Alzheimer's Disease
- O'Brien, Terence (Primary Chief Investigator (PCI))
- Burn, Katherine (Project Manager)
Project: Research